SLC5A2 and diabetes mellitus: Currently available antidiabetic agents, including glucagon-like peptide analogues [38], metformin [28, 39] and SGLT2 inhibitors [40], should excel themselves in diabetes prevention due to their benefits in both weight loss and inflammation reduction.